These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 29893660)

  • 1. Rate of positive cultures necessitating definitive treatment in patients receiving empiric vancomycin therapy.
    Waters CD; Caraccio J
    Infect Control Hosp Epidemiol; 2018 Aug; 39(8):989-990. PubMed ID: 29893660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effectiveness of beta-lactams versus vancomycin for treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections among 122 hospitals.
    McDanel JS; Perencevich EN; Diekema DJ; Herwaldt LA; Smith TC; Chrischilles EA; Dawson JD; Jiang L; Goto M; Schweizer ML
    Clin Infect Dis; 2015 Aug; 61(3):361-7. PubMed ID: 25900170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can Nasal Methicillin-Resistant Staphylococcus aureus Screening Be Used to Avoid Empiric Vancomycin Use in Intra-Abdominal Infection?
    Hennessy SA; Shah PM; Guidry CA; Davies SW; Hranjec T; Sawyer RG
    Surg Infect (Larchmt); 2015 Aug; 16(4):396-400. PubMed ID: 26069990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Negative Methicillin-Resistant Staphylococcus aureus Nasal Surveillance Swabs in Predicting the Need for Empiric Vancomycin Therapy in Intensive Care Unit Patients.
    Chotiprasitsakul D; Tamma PD; Gadala A; Cosgrove SE
    Infect Control Hosp Epidemiol; 2018 Mar; 39(3):290-296. PubMed ID: 29374504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Administration of Adjuvant β-Lactam Therapy in Combination with Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Retrospective, Multicenter Analysis.
    Casapao AM; Jacobs DM; Bowers DR; Beyda ND; Dilworth TJ;
    Pharmacotherapy; 2017 Nov; 37(11):1347-1356. PubMed ID: 28949410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin treatment failure in a vancomycin susceptible methicillin-resistant Staphylococcus aureus (MRSA) infected patient.
    Norazah A; Salbiah N; Nurizzat M; Santhana R
    Med J Malaysia; 2009 Jun; 64(2):166-7. PubMed ID: 20058580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early response assessment to guide management of methicillin-resistant Staphylococcus aureus bloodstream infections with vancomycin therapy.
    Joo J; Yamaki J; Lou M; Hshieh S; Chu T; Shriner KA; Wong-Beringer A
    Clin Ther; 2013 Jul; 35(7):995-1004. PubMed ID: 23829982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active identification of patients who are methicillin-resistant Staphylococcus aureus colonized is not associated with longer duration of vancomycin therapy.
    Acuna-Villaorduna C; Branch-Elliman W; Strymish J; Gupta K
    Am J Infect Control; 2017 Oct; 45(10):1081-1085. PubMed ID: 28629753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of clinical outcome in children and adolescents receiving vancomycin for invasive infections due to methicillin-resistant Staphylococcus aureus: impact of increasing vancomycin MICs.
    Arun A; Swamy S; Jacob K; Sharma R; Kohlhoff SA; Hammerschlag MR
    Minerva Pediatr; 2018 Jun; 70(3):207-211. PubMed ID: 28006894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin versus teicoplanin in the therapy of experimental methicillin-resistant Staphylococcus aureus (MRSA) meningitis.
    Sipahi OR; Arda B; Yurtseven T; Sipahi H; Ozgiray E; Suntur BM; Ulusoy S
    Int J Antimicrob Agents; 2005 Nov; 26(5):412-5. PubMed ID: 16221540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of telavancin in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis: studies with a rabbit model.
    Yin LY; Calhoun JH; Thomas TS; Wirtz ED
    J Antimicrob Chemother; 2009 Feb; 63(2):357-60. PubMed ID: 19060292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus keratitis in rabbits.
    Tas T; Kucukbayrak A; Hakyemez IN; Mengeloglu FZ; Simavli H; Ozyalvacli G; Erdurmus M
    Cornea; 2013 Jul; 32(7):1052-7. PubMed ID: 23665649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can clinical and molecular epidemiologic parameters guide empiric treatment with vancomycin for methicillin-resistant Staphylococcus aureus infections?
    Yamaki J; Lee M; Shriner KA; Wong-Beringer A
    Diagn Microbiol Infect Dis; 2011 May; 70(1):124-30. PubMed ID: 21392923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using MRSA Screening Tests To Predict Methicillin Resistance in Staphylococcus aureus Bacteremia.
    Butler-Laporte G; Cheng MP; Cheng AP; McDonald EG; Lee TC
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7444-7448. PubMed ID: 27736763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of tigecycline VERSUS vancomycin in an experimental model of soft tissue infection by methicillin-resistant Staphylococcus aureus producing Panton-Valentine leukocidin.
    Antonopoulou A; Tsaganos T; Tzepi IM; Giamarellou H; Giamarellos-Bourboulis EJ
    J Chemother; 2015 Feb; 27(2):80-6. PubMed ID: 24548093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current view of vancomycin in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections].
    Martínková J
    Klin Mikrobiol Infekc Lek; 2015 Mar; 21(1):16-23. PubMed ID: 26098489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the treatment of methicillin-resistant Staphylococcus aureus bacteremia.
    Usery JB; Vo NH; Finch CK; Cleveland KO; Gelfand MS; Self TH
    Am J Med Sci; 2015 Jan; 349(1):36-41. PubMed ID: 25233042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia.
    Walraven CJ; North MS; Marr-Lyon L; Deming P; Sakoulas G; Mercier RC
    J Antimicrob Chemother; 2011 Oct; 66(10):2386-92. PubMed ID: 21775337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.
    Arshad S; Huang V; Hartman P; Perri MB; Moreno D; Zervos MJ
    Int J Infect Dis; 2017 Apr; 57():27-31. PubMed ID: 28131729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The empirical combination of vancomycin and a β-lactam for Staphylococcal bacteremia.
    McConeghy KW; Bleasdale SC; Rodvold KA
    Clin Infect Dis; 2013 Dec; 57(12):1760-5. PubMed ID: 23985343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.